Prevention of extravasation injuries secondary to doxorubicin
- 1 March 1985
- journal article
- case report
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 77 (4) , 105-114
- https://doi.org/10.1080/00325481.1985.11698920
Abstract
Intravenously administered drugs with potentially devastating consequences should be given only by personnel highly knowledgeable regarding the side effects and skilled in intravenous cannulation. A strict protocol should be followed. The earliest signs heralding extravasation should be recognized and infusion discontinued immediately. If extravasation occurs, prompt surgical consultation is necessary. Injection into the volar wrist, dorsum of the hand, and antecubital fossa should always be avoided. Polyethylene catheters are preferable to butterfly needles for administering chemotherapeutic agents. A careful history of the venous problems of patients who require long-term therapy should be maintained in their chart. Ideally, vascular access should avoid these problems.Keywords
This publication has 6 references indexed in Scilit:
- Management of extensive doxorubicin hydrochloride extravasation injuriesThe Journal of Hand Surgery, 1983
- The Anthracycline Antineoplastic DrugsNew England Journal of Medicine, 1981
- Use of sodium bicarbonate as a means of ameliorating doxorubicin-induced dermal necrosis in ratsCancer Chemotherapy and Pharmacology, 1980
- The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouseCancer Chemotherapy and Pharmacology, 1980